Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3028313 | 0.86 | RECQL (0.49) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL2187664 | 0.85 | LMNA (0.55) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL2187654 | 0.85 | LMNA (0.55) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL2187658 | 0.85 | LMNA (0.55) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL974014 | 0.84 | TDP1 (0.56) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL27773303 | 0.84 | TDP1 (0.56) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL2946253 | 0.83 | RECQL (0.60) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL2946252 | 0.83 | RECQL (0.60) | LMNATDP1CES2CES1RECQL | |
| SCHEMBL7867316 | 0.83 | MEN1 (0.60) | LMNATDP1CES2CES1MEN1 | |
| SCHEMBL3151573 | 0.82 | LMNA (0.58) | LMNATDP1CES2CES1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10309212-B2 | Energetic cocrystals for treatment of a subterranean formation | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-10253244-B2 | Scale-inhibiting cocrystals for treatment of a subterranean formation | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20160177698-A1 | ENERGETIC COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION | HALLIBURTON ENERGY SERVICES, INC. | 2016-06-23 | — | — | US | disclosed |
| US-20160130496-A1 | SCALE-INHIBITING COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION | HALLIBURTON ENERGY SERVICES, INC. | 2016-05-12 | — | — | US | disclosed |
| EP-2292585-B1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT WEST LAFAYETTE LLC (US) | 2016-04-27 | — | — | EP | disclosed |
| WO-2015034478-A1 | SCALE-INHIBITING COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-03-12 | — | — | WO | disclosed |
| WO-2015030730-A1 | ENERGETIC COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-2292585-A1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT (KANSAS CITY), LLC (US) | 2011-03-09 | — | — | EP | disclosed |